These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2227636)

  • 1. Fungal infection and haematological malignancies: a report about association therapy with amphotericin B and 5-flucytosine in primary lung involvement.
    Pogliani E; Clini E
    Haematologica; 1990; 75(3):304-5. PubMed ID: 2227636
    [No Abstract]   [Full Text] [Related]  

  • 2. Mycological-diagnostic assessment of the efficacy of amphotericin B + flucytosine to control Cryptococcus neoformans in AIDS patients.
    Staib F; Seibold M
    Mycoses; 1988 Apr; 31(4):175-86. PubMed ID: 3405247
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic usefulness. 5-Fluorocytosine--a new anti-fungal agent.
    Drevets CC; Hummer LM
    J Kans Med Soc; 1975 May; 76(5):103-7. PubMed ID: 1168678
    [No Abstract]   [Full Text] [Related]  

  • 4. Resolution of cryptococcal meningitis and associated granuloma lung with antifungal therapy: report of a case.
    Ray D; Gnanamuthu C
    Indian J Chest Dis Allied Sci; 1994; 36(3):153-8. PubMed ID: 7737703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chemotherapy of aspergillus lung disease].
    Scholer HJ
    Mykosen; 1983 Apr; 26(4):173-96. PubMed ID: 6306462
    [No Abstract]   [Full Text] [Related]  

  • 6. Cryptococcosis.
    Friedlander M; Gelfand M
    Cent Afr J Med; 1977 Apr; 23(4):73-7. PubMed ID: 862016
    [No Abstract]   [Full Text] [Related]  

  • 7. Early empiric antifungal therapy of infections in neutropenic patients comparing fluconazole with amphotericin B/flucytosine.
    Silling G; Fegeler W; Roos N; Essink M; Büchner T
    Mycoses; 1999; 42 Suppl 2():101-4. PubMed ID: 10865914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A cured case of primary pulmonary cryptococcosis with cryptococcal meningitis].
    Kitano M; Takeuchi Y; Matsui T; Asakura S; Fujio A; Aihara M
    Rinsho Kyobu Geka; 1985; 5(2):243-7. PubMed ID: 9423011
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis.
    Schwarz P; Dromer F; Lortholary O; Dannaoui E
    Antimicrob Agents Chemother; 2006 Jan; 50(1):113-20. PubMed ID: 16377675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive pulmonary aspergillosis in a non-immunosuppressed patient: successful management with systemic amphotericin and flucytosine and inhaled amphotericin.
    Rodenhuis S; Beaumont F; Kauffman HF; Sluiter HJ
    Thorax; 1984 Jan; 39(1):78-9. PubMed ID: 6695357
    [No Abstract]   [Full Text] [Related]  

  • 11. [Curative treatment of invasive aspergillosis].
    Dupont B
    Pathol Biol (Paris); 1994 Sep; 42(7):688-93. PubMed ID: 7877863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of cryptococcal meningitis with triple combination of amphotericin B, flucytosine and itraconazole.
    Chotmongkol V; Jitpimolmard S
    Southeast Asian J Trop Med Public Health; 1995 Jun; 26(2):381-3. PubMed ID: 8629082
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of respiratory mycoses (author's transl)].
    Wegmann T
    Ther Umsch; 1975 Apr; 32(4):269-73. PubMed ID: 1145528
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diagnosis and treatment of indigenous lung mycoses].
    Wegmann T
    Schweiz Rundsch Med Prax; 1977 Jul; 66(28):861-4. PubMed ID: 877006
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical aspects and therapy of candidiasis in pneumological patients].
    Perruchoud A; Kobza K; Kopp C; Mihatsch M; Herzog H
    Schweiz Med Wochenschr; 1977 Feb; 107(6):192-4. PubMed ID: 834994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug combinations in the treatment of invasive aspergillosis].
    Esposito R; Lazzarin A; Rossi E
    G Ital Chemioter; 1984; 31(1-2):169-72. PubMed ID: 6381204
    [No Abstract]   [Full Text] [Related]  

  • 17. Association therapy as a prognostic factor in deep fungal infection complicating oncohaematological diseases.
    Pogliani E; Clini E
    Support Care Cancer; 1994 Nov; 2(6):385-8. PubMed ID: 7858932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary aspergillosis complicating aplastic phase in hematologic patients.
    Capnist G; Chisesi T; Battista R; Dini E
    Haematologica; 1986; 71(3):201-4. PubMed ID: 3093323
    [No Abstract]   [Full Text] [Related]  

  • 19. [Invasive aspergillar pneumopathy during the treatment of microcellular bronchial cancer. Efficacy of early antifungal treatment].
    Pauli G; Dietemann-Molard A; Pujol JL; Roegel E
    Rev Mal Respir; 1985; 2(6):361-4. PubMed ID: 3012720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The treatment of pulmonary fungal infections: the results and the problems (author's transl)].
    Matsushima T; Yagi S; Hara H; Soejima R; Nakashima T; Fujii Y; Hara Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1980 Oct; 18(10):739-46. PubMed ID: 7241871
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.